2021
DOI: 10.1093/ve/veab058
|View full text |Cite
|
Sign up to set email alerts
|

Human genomics of the humoral immune response against polyomaviruses

Abstract: Human polyomaviruses are widespread in humans and can cause severe disease in immunocompromised individuals. To identify human genetic determinants of the humoral immune response against polyomaviruses, we performed genome-wide association studies and meta-analyses of qualitative and quantitative immunoglobulin G (IgG) responses against BK (BKPyV), JC (JCPyV), Merkel Cell (MCPyV) and WU (WUPyV) polyomaviruses and Human polyomavirus 6 (HPyV6) in 15,660 individuals of European ancestry from three independent stu… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
12
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 12 publications
(13 citation statements)
references
References 72 publications
1
12
0
Order By: Relevance
“…Of particular interest is the identification of multiple variants in NFKB1 as a common locus associated with antibody responses across multiple pathogens and pathogen types, including EBV, human papillomavirus type 18 (HPV18), HIV, HTLV-1, Kaposi’s sarcoma-associated herpesvirus (KSHV), and T. gondii . To confirm the likely contribution of this locus to multiple infectious antigen responses we replicated this association demonstrating a consistent direction of effect for three antigens (EBV EAD, EBV ZEBRA and HHV-7 U14) using an independently recruited cohort (CoLaus/PsyCoLaus; see Supplementary Table 2, Extended Data Table 4, 16 ) where data using the same Multiplex Serology technology was available but with a different set of antigens (Fig. 1b).…”
Section: Main Textmentioning
confidence: 71%
See 1 more Smart Citation
“…Of particular interest is the identification of multiple variants in NFKB1 as a common locus associated with antibody responses across multiple pathogens and pathogen types, including EBV, human papillomavirus type 18 (HPV18), HIV, HTLV-1, Kaposi’s sarcoma-associated herpesvirus (KSHV), and T. gondii . To confirm the likely contribution of this locus to multiple infectious antigen responses we replicated this association demonstrating a consistent direction of effect for three antigens (EBV EAD, EBV ZEBRA and HHV-7 U14) using an independently recruited cohort (CoLaus/PsyCoLaus; see Supplementary Table 2, Extended Data Table 4, 16 ) where data using the same Multiplex Serology technology was available but with a different set of antigens (Fig. 1b).…”
Section: Main Textmentioning
confidence: 71%
“…Genetic analyses of antibody response levels against vaccine preventable infections, such as hepatitis B virus, have demonstrated a strong influence of genetic loci, including the major histocompatibility locus (MHC) in predicting antibody magnitude overlapping with GWAS of disease susceptibility 14 . The MHC has also been implicated in varied antibody responses to infections including JC virus, and influenza [15][16][17] . Furthermore, primary immunodeficiencies such as common variable immunodeficiency (CVID) and X-linked agammaglobulinaemia are well recognised disorders that increase the risk of multiple infections owing to impaired humoral function and antibody deficiencies [18][19][20] .…”
Section: Main Textmentioning
confidence: 99%
“…DNA samples from 5399 CoLaus|PsyCoLaus participants were genotyped for 799,653 SNPs using the BB2 GSK-customized Affymetrix Axiom Biobank array. Quality control procedures and imputation of genotypes have been previously described in Hodel et al [ 23 ]. A total of 9,031,263 SNPs from the CoLaus|PsyCoLaus dataset were included for further analyses (flowchart of the inclusion/exclusion criteria are in Additional file 1 : Fig.…”
Section: Methodsmentioning
confidence: 99%
“…The BB2 GSK-customized Affymetrix Axiom Biobank array was used to genotype DNA samples from 5’399 participants at approximately 800’000 single nucleotide polymorphisms (SNPs). After genotype imputation and quality control procedures, approximately 9 million SNPs were available for analysis (30). We then calculated, based on the risk effects of common SNPs, the CHD polygenic risk score (PRS) for each study participant.…”
Section: Methodsmentioning
confidence: 99%